ValCare Medical

Minimally Invasive Treatment for Valve Disease

Health Tech & Life Sciences
Active
Seed Herzliya Founded 2012
Total raised
$23.0M
Last: 2023-11
Stage
Seed
Founded
2012
Headcount
30
HQ
Herzliya
Sector
Health Tech & Life Sciences

About

Valcare Medical is dedicated to providing innovative minimally-invasive technologies for the treatment of mitral and tricuspid regurgitation. Its product line includes solutions for the repair and replacement of the mitral valve and repair of the tricuspid valve. The company’s breakthrough mitral valve treatment platform is based on a D-shaped ring that serves as both a highly effective tool for mitral annulus repair and a docking station for Valcare’s exclusive replacement prosthesis.

Funding history · 3 rounds · $23.0M total

2023-11
Undisclosed Round Undisclosed
2018-09
Undisclosed $15.0M
2012-07
Seed $8.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

surgeryvalvescathetersmedical-devicesminimally-invasivecardiologysurgeonshospitalstreatments